🟢 Tiziana Life Sciences is trading 9.72% up in pre-market

Tiziana Life Sciences is trading 9.72% up in pre-market at $1.23; available evidence does not establish a specific catalyst for the move.

• The shares closed at $1.12 on October 2, after several sessions near or below $1.00.
• The latest company-specific announcement located was the September 30 FDA orphan-drug designation filing for intranasal foralumab in multiple system atrophy; the company’s release list shows no newer announcement through October 5.
• Broad indices are slightly lower.